Cargando…

Treatment Strategy after Incomplete Endoscopic Resection of Early Gastric Cancer

Endoscopic resection of early gastric cancer is defined as incomplete when tumor cells are found at the resection margin upon histopathological examination. However, a tumor-positive resection margin does not always indicate residual tumor; it can also be caused by tissue contraction during fixation...

Descripción completa

Detalles Bibliográficos
Autor principal: Kim, Sang Gyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Gastrointestinal Endoscopy 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977745/
https://www.ncbi.nlm.nih.gov/pubmed/27435699
http://dx.doi.org/10.5946/ce.2016.069
_version_ 1782447090424610816
author Kim, Sang Gyun
author_facet Kim, Sang Gyun
author_sort Kim, Sang Gyun
collection PubMed
description Endoscopic resection of early gastric cancer is defined as incomplete when tumor cells are found at the resection margin upon histopathological examination. However, a tumor-positive resection margin does not always indicate residual tumor; it can also be caused by tissue contraction during fixation, by the cautery effect during endoscopic resection, or by incorrect histopathological mapping. Cases of highly suspicious residual tumor require additional endoscopic or surgical resection. For inoperable patients, argon plasma coagulation can be used as an alternative endoscopic treatment. Immediately after the incomplete resection or residual tumor has been confirmed by the pathologist, clinicians should also decide upon any additional treatment to be carried out during the follow-up period.
format Online
Article
Text
id pubmed-4977745
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Korean Society of Gastrointestinal Endoscopy
record_format MEDLINE/PubMed
spelling pubmed-49777452016-08-09 Treatment Strategy after Incomplete Endoscopic Resection of Early Gastric Cancer Kim, Sang Gyun Clin Endosc Review Endoscopic resection of early gastric cancer is defined as incomplete when tumor cells are found at the resection margin upon histopathological examination. However, a tumor-positive resection margin does not always indicate residual tumor; it can also be caused by tissue contraction during fixation, by the cautery effect during endoscopic resection, or by incorrect histopathological mapping. Cases of highly suspicious residual tumor require additional endoscopic or surgical resection. For inoperable patients, argon plasma coagulation can be used as an alternative endoscopic treatment. Immediately after the incomplete resection or residual tumor has been confirmed by the pathologist, clinicians should also decide upon any additional treatment to be carried out during the follow-up period. Korean Society of Gastrointestinal Endoscopy 2016-07 2016-07-20 /pmc/articles/PMC4977745/ /pubmed/27435699 http://dx.doi.org/10.5946/ce.2016.069 Text en Copyright © 2016 Korean Society of Gastrointestinal Endoscopy This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Kim, Sang Gyun
Treatment Strategy after Incomplete Endoscopic Resection of Early Gastric Cancer
title Treatment Strategy after Incomplete Endoscopic Resection of Early Gastric Cancer
title_full Treatment Strategy after Incomplete Endoscopic Resection of Early Gastric Cancer
title_fullStr Treatment Strategy after Incomplete Endoscopic Resection of Early Gastric Cancer
title_full_unstemmed Treatment Strategy after Incomplete Endoscopic Resection of Early Gastric Cancer
title_short Treatment Strategy after Incomplete Endoscopic Resection of Early Gastric Cancer
title_sort treatment strategy after incomplete endoscopic resection of early gastric cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977745/
https://www.ncbi.nlm.nih.gov/pubmed/27435699
http://dx.doi.org/10.5946/ce.2016.069
work_keys_str_mv AT kimsanggyun treatmentstrategyafterincompleteendoscopicresectionofearlygastriccancer